What Are Operating Costs For Total Artificial Heart Program?
Total Artificial Heart Program Running Costs
Running a Total Artificial Heart Program demands substantial fixed overhead and high variable costs, driven by specialized staff and device procurement Expect initial monthly fixed costs around $371,000, covering facility leases, insurance, and core administrative wages in 2026 Variable costs, including the TAH device and surgical kits, account for about 205% of revenue While the program achieves break-even quickly (1 month), the initial capital expenditure (CapEx) leads to a minimum cash requirement of $3387 million by June 2026 You must secure this working capital to cover the ramp-up period before revenue stabilizes
7 Operational Expenses to Run Total Artificial Heart Program
#
Operating Expense
Expense Category
Description
Min Monthly Amount
Max Monthly Amount
1
Staff Payroll
Wages
Core administrative and leadership wages total $145,416 monthly.
$145,416
$145,416
2
Facility Lease
Facility Fixed Cost
Specialized Facility Lease is the single largest fixed operating expense at $120,000 per month.
$120,000
$120,000
3
Device COGS
Variable Cost
TAH Device and Surgical Kits represent 150% of procedure revenue.
$0
$0
4
Malpractice Insurance
Risk Management
Medical Malpractice Insurance is budgeted at $45,000 monthly for the high-risk program.
$45,000
$45,000
5
FDA Compliance
Regulatory Overhead
Maintaining regulatory approval requires a fixed monthly budget of $15,000 for compliance.
$15,000
$15,000
6
EHR Licensing
Technology Licensing
EHR and Remote Monitoring Licensing costs $8,500 monthly for patient data management.
$8,500
$8,500
7
Physician Outreach
Business Development
Marketing and Physician Outreach is budgeted at $25,000 monthly to secure referrals.
$25,000
$25,000
Total
All Operating Expenses
$358,916
$358,916
What is the total required monthly operating budget for the first 12 months?
The total required monthly operating budget for the Total Artificial Heart Program starts with a $371k fixed cost floor, but the 205% variable cost structure means revenue must immediately outpace costs to avoid hitting the projected $3,387M cash low point, which you can read more about here: How Much Does An Owner Make From Total Artificial Heart Program? Honestly, that variable cost ratio is the biggest immediate red flag you'll face in the first 12 months.
Fixed Cost Baseline
Staff and overhead fixed costs are $371,000 per month.
This is your minimum operational burn rate.
It covers essential, non-volume-dependent expenses.
You defintely need 12 months of this covered upfront.
Variable Cost Risk
Variable costs are projected at 205% of revenue.
This implies that for every dollar earned, you spend $2.05.
This structure requires massive gross margins on procedures.
The cash low point estimate is $3,387M.
Which cost categories represent the largest recurring monthly expenses?
The largest recurring expenses for the Total Artificial Heart Program are clearly the specialized facility lease, medical malpractice insurance, and the cost of the devices; understanding how to manage these levers is key, so review What Are The 5 KPIs For Total Artificial Heart Program? for performance tracking.
Fixed Overhead Hitters
The specialized facility lease is a huge fixed cost at $120,000 per month.
Medical malpractice insurance is defintely the second largest fixed drain, running $45,000 monthly.
These two items alone account for $165,000 in overhead before treating one patient.
You must secure high utilization in that specialized space to cover this baseline.
The Margin Killer
The Total Artificial Heart (TAH) device Cost of Goods Sold (COGS) is the biggest variable threat.
Device COGS hits 120% of revenue, meaning you lose money on every procedure performed.
This negative gross margin requires immediate action on procurement or pricing structure.
If revenue is $500k, device costs are $600k, creating an immediate $100k operational hole.
How much working capital is needed to cover operations before positive cash flow?
The Total Artificial Heart Program needs $3387M in minimum cash to sustain operations until collections and capital expenditure (CapEx) deployment stabilizes, projecting this runway requirement through June 2026; understanding how to manage this period is crucial, as detailed in resources covering metrics like What Are The 5 KPIs For Total Artificial Heart Program?
Required Cash Buffer
Minimum cash required is $3387M.
This covers the operational burn rate.
Stabilization date targeted for June 2026.
Crucial to cover costs before collections arrive.
Operational Coverage
Funds specialized surgical implantation costs.
Covers ongoing device management fees.
Defintely supports multidisciplinary team salaries.
Ensures patient care continuity regardless of payment lag.
If procedure volume is 50% below forecast, how will we cover fixed overhead?
If procedure volume for the Total Artificial Heart Program falls 50% below forecast, you will immediately face a substantial operating cash shortfall against the $371k fixed overhead, making the initial 15-month payback goal defintely unattainable without drastic action.
Covering the Fixed Cost Gap
Fixed overhead stands at $371,000 monthly.
A 50% volume reduction cuts variable revenue by half.
You must cover the entire fixed cost plus the lost contribution margin.
If variable contribution margin is 55%, the monthly shortfall is about $102k.
Payback Period Extension
The 15-month payback relies on hitting forecast contribution targets.
This volume drop forces a complete re-evaluation of capital recovery timing.
The total baseline monthly fixed and administrative overhead for the Total Artificial Heart Program is projected to be approximately $371,000 in 2026.
Variable costs associated with the TAH device and surgical kits are extremely high, consuming 205% of procedure revenue.
To sustain operations through the initial ramp-up phase until revenue stabilizes, a minimum working capital requirement of $3.387 million must be secured.
Despite the heavy initial investment and high overhead, the program is modeled to achieve payback on its investment within 15 months.
Running Cost 1
: Staff Payroll
Core Leadership Pay
Core leadership and administrative payroll hits $145,416 monthly in 2026. This fixed cost covers essential high-level roles needed to run a specialized center of excellence for Total Artificial Heart procedures. This number is a baseline expense you must cover before any revenue comes in.
Fixed Wage Breakdown
This $145,416 monthly payroll is a fixed operating cost for 2026. It covers the Medical Director at $45,833/mo and the Chief Surgical Officer at $62,500/mo, plus necessary support staff wages. This is a foundational expense required regardless of patient volume.
Medical Director: $45,833/mo
CSO: $62,500/mo
Support staff wages included.
Managing Executive Burden
High fixed salaries demand high utilization to justify the expense. Avoid hiring support staff defintely before they're needed; use fractional expertise for initial admin needs. If the Medical Director and CSO aren't fully utilized, the cost-to-serve per procedure spikes fast.
Tie bonuses to procedure volume targets.
Use fractional roles initially where possible.
Ensure utilization covers the $108,333 executive base.
Payroll vs. Procedure Volume
The executive team alone costs $108,333 monthly. To cover just this portion with a 50% gross margin goal, you need roughly $216,666 in procedure revenue just for these two roles. Plan your initial procedure throughput carefully to absorb this fixed cost.
Running Cost 2
: Facility Lease
Lease Weight
The specialized facility lease for the Total Artificial Heart Program is your biggest fixed overhead, hitting $120,000 monthly. This figure doesn't even include the extra costs for utilities or specialized equipment upkeep, so watch those add-ons closely. This is a massive, non-negotiable cost base to clear.
Lease Inputs
This $120k covers the dedicated surgical suite and long-term patient management space required for TAH procedures. To model this accurately, you need the signed lease terms, including escalation clauses and any amortization schedules for required build-outs. It's a huge fixed cost that must be covered before you see profit.
Signed lease agreement terms.
Monthly rent figure: $120,000.
Factor in utility/maintenance buffers.
Managing Fixed Space
Since this expense is fixed, reducing it means negotiating better upfront terms or finding a smaller initial footprint for the specialized center. A common mistake is signing a long lease requiring massive tenant improvements you can't easily exit. Defintely push hard for tenant improvement allowances to offset initial capital outlay.
Negotiate tenant improvement credits.
Phase facility expansion plans carefully.
Ensure exit clauses are favorable.
Break-Even Driver
Because the lease is $120,000 fixed, your break-even point is heavily dictated by utilization rates. Your payroll costs are actually higher at $145,416 monthly, so facility cost alone means you need high procedure density just to cover the building before you pay your leadership team.
Running Cost 3
: Device COGS
Unsustainable COGS
Your device cost structure is unsustainable right now. In 2026, the combined cost of the TAH device, kits, and consumables hits 150% of procedure revenue. This means every procedure booked loses money before factoring in fixed overhead.
Device Cost Breakdown
This 150% figure is derived from two main buckets tied directly to volume. The TAH device and surgical kits alone cost 120% of procedure revenue. Specialized consumables add another 30% on top of that. You need firm quotes for the device and kits to validate the 120% assumption, as this is the primary driver.
TAH Device & Kits: 120% of procedure revenue.
Consumables: An additional 30% margin cost.
Total COGS: 150% of revenue.
Cutting Device Costs
You can't operate profitably with COGS at 150% of revenue; this requires immediate negotiation. Focus on securing better pricing tiers for the core TAH device, perhaps by committing to a minimum volume over three years. Also, review if the 30% consumable cost can be reduced by using approved, lower-cost alternatives for non-critical items. Defintely push for volume discounts.
Negotiate device pricing based on projected volume.
Audit consumable usage for waste or overstocking.
Target a COGS reduction below 100% immediately.
Profitability Hurdle
The 150% COGS means that even if your fixed costs were zero-no payroll, no lease-you would still lose 50 cents for every dollar of procedure revenue booked. This cost structure must be addressed before scaling any patient volume. It's a hard stop.
Running Cost 4
: Malpractice Insurance
Insurance Cost Set
Malpractice insurance is a fixed operating expense of $45,000 monthly for the specialized heart program. This cost directly reflects the inherent, high-stakes risk associated with Total Artificial Heart implantation and management.
Fixed Cost Breakdown
This $45,000/month premium is a non-negotiable fixed operating expense, unlike variable costs like Device COGS (150% of revenue). You must budget this amount monthly, regardless of patient volume, because it covers liability for high-acuity procedures like TAH implantation. If the program scales to 10 patients a month, this cost remains static.
Fixed monthly premium.
Covers TAH liability risk.
Budgeted for 2026 operations.
Managing Insurance Spend
Since this is fixed, savings come from negotiating policy terms, not reducing volume. Avoid common mistakes like underinsuring, which invites catastrophic risk given the $120,000 facility lease and high payroll. You might explore multi-year commitments for a potential 5% discount, but never compromise coverage limits for this critical area.
Negotiate multi-year terms.
Benchmark against similar centers.
Do not lower coverage limits.
Risk Profile Impact
The $45,000 premium signals the market's perception of the Total Artificial Heart Program's risk. This number is significantly higher than general cardiology coverage due to the complexity and novelty of the procedures performed. It's a necessary expense for operating in this specialized space.
Running Cost 5
: FDA Compliance
Fixed Regulatory Cost
You must budget $15,000 monthly just to keep the Total Artificial Heart Program compliant with the Food and Drug Administration (FDA). This covers ongoing Quality Monitoring activities necessary to maintain your device approvals. This fixed operating expense is non-negotiable for market access, period.
Compliance Budget Breakdown
This $15,000 covers the necessary overhead for regulatory adherence, separate from initial device COGS. It's a fixed cost, meaning it doesn't change based on patient volume, unlike the 150% Device COGS figure. You need this budget locked in monthly to avoid operational shutdowns.
Covers Quality Monitoring costs.
Fixed monthly overhead component.
Essential for maintaining device approval.
Managing Compliance Spend
You can't cut this cost without risking approval, but you can manage how you spend it. Avoid using expensive external consultants for routine monitoring if internal staff can handle standard reporting. A common mistake is underestimating the time needed for documentation audits, which drives up consulting fees.
Internalize routine reporting tasks.
Benchmark compliance staff utilization.
Audit documentation processes yearly.
Regulatory Risk Check
If you miss this $15,000 payment, you stop monitoring quality, which immediately triggers a regulatory risk event. This cost is small compared to the $45,000 Malpractice Insurance, but failure here stops all revenue generation dead. Don't treat compliance as optional overhead, it's the license to operate.
Running Cost 6
: EHR Licensing
Licensing Spend
The monthly cost for necessary patient data systems is fixed. You must budget $8,500 per month for Electronic Health Record (EHR) and remote monitoring licensing to support post-operative care protocols. This cost is non-negotiable for compliance and continuity.
Data System Cost
This $8,500 monthly fee covers the software infrastructure required for continuous patient oversight. It bundles EHR access with remote monitoring tools essential for tracking implanted device function post-surgery. This is a fixed operating expense, not tied to procedure volume.
Covers EHR access.
Includes Remote Monitoring tools.
Fixed at $8,500/month.
Manage Licensing
Licensing costs are sticky but can be optimized before signing multi-year agreements. Check if bundled pricing for the EHR and remote monitoring platform offers discounts for volume commitments beyond the first year. You should defintely not pay for unused user seats.
Negotiate multi-year terms.
Audit active user licenses.
Check for platform bundling deals.
Compliance Check
If you scale patient volume rapidly, ensure your existing $8,500 license tier supports the increased data load without triggering expensive, immediate upgrades. Unexpected scaling fees kill contribution margins fast.
Running Cost 7
: Physician Outreach
Outreach Budget Reality
Physician outreach costs $25,000 monthly to drive referrals into your Total Artificial Heart Program. This expense is crucial for building trust with referring cardiologists and surgeons. Without consistent outreach, patient volume stalls, making it impossible to cover your high fixed costs like the $120,000 facility lease.
Referral Spend Inputs
This $25,000 budget funds activities designed to reach referring physicians and hospital systems. It covers marketing materials, travel for relationship building, and potentially hiring a dedicated liaison. Compared to the $145,416 payroll or $120,000 lease, it's a manageable spend necessary for patient acquisition.
Covers referral development costs.
Supports community reputation building.
Essential for patient pipeline flow.
Managing Referral Costs
You must track the Cost Per Qualified Referral (CPQR) generated by this spend. Avoid broad advertising; focus resources on high-yield interactions, like sponsoring specific surgical society meetings. If travel costs balloon, consider virtual engagement first. Honestly, if you don't track ROI, this $25k is defintely a sunk cost.
Track Cost Per Qualified Referral.
Prioritize direct physician engagement.
Benchmark against industry standards.
Outreach vs. Device Costs
Remember, your Device COGS alone is 150% of procedure revenue. Therefore, every patient secured via outreach must be high-value and ideally progress quickly through the treatment pathway. This outreach spend is a prerequisite for revenue that must cover massive upfront device costs and $45,000 in malpractice insurance.
